|
 
- 积分
- 3495
- 威望
- 3495
- 包包
- 4879
|
 
美国冷泉港和国际干细胞协会（ISSCR）联合举办的细胞编程和重编程会议（Joint CSH Asia/ISSCR Conference on Cellular Programs & Reprogramming），于2011-10-24晚到2011-10-28中午结束，共开了3天半。来自世界各地的46个演讲者，围绕以下范围：1.Human Stem Cells; 2.Control of Pluripotency; 3.Differentiation Mechanisms; 4..Cell Interactions; 5.Molecular Control; 6.Cell Lineage; 7.Cell Therapies. 进行演讲。只采取全体大会演讲的形式，没有分会场交流。全体参会人数约430人，国内参会者应在一半以上。6 q, o7 E5 ?) V, q5 R; W7 P
) ?% }6 S7 e, h( D几点参会评论：
- m$ }2 {" I& z% B, g( B( x9 O1.本次会议演讲范围较广，主要是干细胞的基础演讲，大概2个演讲者提到干细胞临床治疗，因此对临床医师受益有限。
# k% O1 o/ q6 {& N, S/ a% O3 [2.许多国际著名干细胞领域权威给予精彩演讲，且绝大部分演讲内容未发表，但视乎没有让人感觉“耳目一新、眼前一亮”的报告。
7 Y" {: L- p$ M; j3.国内干细胞大牛仅裴端卿、邓宏魁参会（小牛惠立建也给talk），这样的干细胞国际盛会，又是在中国举办，国内其他干细胞大牛到了哪里？为什么不参会？我非常想见到国内权威能向国际权威提几个精彩的问题，并进行辩论，但可惜没看到，只是邓宏魁、惠立建各提了一个基本的问题。国内研究生参会较多，且提问较积极，虽然问题较基本、英文发音不准，但不怯场，值得表扬。
6 L! i/ y8 |! |4.国际大佬基本上天天参会，较容易见到，也愿意回答问题，如国际皮肤干细胞的权威Elaine Fuchs教授，经常提问题，也天天被学生包围，不像国内某些大佬，一演讲完就找不到人了，像是怕见人。
# J- M# g5 W4 [2 [4 u5.大家几乎一致认为会议组织的很好，住宿条件非常好，5星级宾馆，宾馆周围环境非常优美。会议伙食也非常好，已听到多人抱怨说吃胖了，回去要减肥。本人多次在国外参加ISSCR组织的年会，不得不说这是吃得最好的一次。会议结束前晚组织的具有苏州特色的文艺表演，让一些国外参会者看的眼都直了。& Q5 f" r8 i# M9 |
9 T$ U& O( I! s- [
大会演讲嘉宾有：
/ L7 V, I- Y Q: x4 W3 X1.Monday, October 24
: k6 _% c! u* Y0 ?7 }1 V, m6 I7 xWelcome and Overview ' _. D$ ^5 H1 G& r
Chairperson: Ronald D. McKay, PhD/ ?) |& [$ U- M1 z: Y$ S4 x
+ ~' ]3 x6 {# L9 ]2 L9 NOpening Keynote: Elaine Fuchs, PhD, The Rockefeller University, USA
5 p. ^- a, `: G8 h( \6 [0 Z7 s& K* i# n, I: W. g
2.Tuesday, October 25 Session I: Human Stem Cells- `8 P/ R0 m$ ~) @# P
Chairperson: Hongkui Deng, PhD m: H, p2 f% F! H) Y( ?" L
6 C' H5 d4 [, QFred Gage, PhD, Salk Institute for Biological Studies, USA ! g [2 H R, J- z7 y1 A; U' G2 d
Esther Y. Son, Howard University
" D; l5 G7 k; J9 _$ j1 p8 sGong Chen, Pensylvania state University,! G0 O5 O3 p2 ]' j# n
Wolf Reik, MD, PhD, The Babraham Institute, United Kingdom ! n0 e+ j1 j% T5 T, D4 k: M. x
Linzhao Cheng, PhD, Johns Hopkins University, USA 0 I0 U; i6 _, X+ y0 w5 T# S
Meng Li, Imperial College London: T' h( d* [5 D1 o7 Y* e' _8 u
Joan Li, University of Gueensland
b5 y3 C6 q% }6 }" [Richard A. Young, PhD, Whitehead Institute/M.I.T., USA
. K9 e1 H) J8 o2 z6 P9 k( k3 J. Y( g; [0 ~! ^2 \+ f: {+ Z
3.Session II: Control of Pluripotency
1 E; n$ p' k& {" x. r! B. h) {. SChairperson: Hongkui Deng, PhD" f; S7 q2 T, A Q- U: i
3 M H! n, w3 M' DMarius Wernig, MD, Stem Cell Institute, Stanford University, USA% Y5 \9 _" c7 |& l, U4 @4 j
Wenyu Zhou, University of Washington
) \ g3 I' z( y$ J7 V! uShuibing Chen, Weill Cornell Medical College2 u" t' m/ A) P! B+ ^. R
Jennifer Nichols, PhD, Cambridge Stem Cell Initiative, University of Cambridge, UK7 U% p* }* t, X7 l4 X6 b
Yi Zhang, PhD, University of North Carolina, USA% ]/ e8 ]6 W& Y( S" ~ x' |
Alice E. Chen, Stemgene Inc., Cambage
5 |4 h" D" \6 f1 \$ VHitoshi Niwa, MD, PhD, Riken Center for Developmental Biology, Japan ( ^- g0 }( q: v3 ~$ v- R* [, s3 d
* z1 B% i1 u1 p4 @0 h- u7 R
4.Session III: Poster presentations with refreshments
# e7 v2 L9 Z9 f; J, c% A) h- ^, [# {4 A
5. Wednesday, October 26 Session IV: Differentiation Mechanisms : Z9 [, W h9 x1 M
Chairperson: V. Narry Kim, DPhill; D3 \$ o) @' L* ^& `; P$ I
" z* {/ Z; r$ b- }0 v* @Duanqing Pei, PhD, Guangzhou Institute of Biomedicine and Health, China " D; `7 o" C6 S
Feng Ma, CAMC,! N9 ?: r ~4 Q- v1 l5 f: E
Eric Deneault, University of Montreal,- {; m% H7 o, U/ ] O
Hongkui Deng, PhD, Peking University, China9 W5 ?' f& u7 r# L
Deepak Srivastava, MD, Gladstone Institute of Cardiovascular Disease, USA' F! A, @& n' u0 I( g
Lijian HUI, Shanghai,: F% n* T3 b! _0 a' H" F4 ^
Fiona Watt, DPhil, Cancer Research UK Cambridge Research Institute, United Kingdom9 M8 z7 e9 H& z3 |" k
; n! o' @: u8 d1 F
6.Session V: Cell Interactions 7 p$ D5 v/ h) `. d& g( n* ~: v
Chairperson: V. Narry Kim, DPhill9 o( S( |8 k7 c9 `
8 M, T- R: O% S9 [5 y0 }Linheng Li, PhD, Stowers Institute for Medical Research, USA
( T) J- r! L6 s1 J0 l: u: ]7 x! aFeng Liu, Zoology of China
" _/ _" _1 {1 p0 V5 r- {+ h) @9 qHiromitsu Nakauchi, MD, PhD, Institute of Medical Science, University of Tokyo, Japan
# j% ~! A/ x5 b- q9 GToshio Suda, MD, Keio University School of Medicine, Japan" x' X5 m3 \9 M- Q: m& G. P
Guoping Fan, UCLA
3 i, E7 y) r& d0 [! S5 v3 LHideyuki Okano, MD, PhD, Keio University School of Medicine, Japan
& [7 K, X; v0 N0 M! G" |% h2 P# J( o5 g
7. Thursday, October 27
# c4 @' Q! g" n/ |- B7 ^ wSession VI: Molecular Control
0 q' X- M- G: N# O+ Q$ BChairperson: Richard A. Young, PhD
0 K, Q# Q7 s$ @1 P
7 j* T$ W U) a0 nJoanna Wysocka, PhD, Stanford University, USA0 n6 n; j+ o# I1 V! G
Lin He, UC Berkeley8 E3 J5 \& ~. L
Andrew Xiao, Yale University8 n4 @3 l9 t* _4 l
V. Narry Kim, DPhil, Seoul National University, Korea
: d9 f4 X& n- M4 p+ E7 a( \Yukiko Gotoh, PhD, University of Tokyo, Japan$ V4 y! f3 K0 l9 b6 p. e
Gang Wang, CAS, China$ B3 E! ^! i) F; Z) R
Shengxi Guan, New England Biolab7 y( `+ W: S/ Q+ _ |9 Z
Zhaoyu Lin, Nanjing University
+ k: A" D0 s, sHaifan Lin, PhD, Yale University School of Medicine, USA
7 O' v* b p, h, Q8 M5 ~
$ m/ G ~! `2 O8.Session VII: Cell Lineage
5 C9 k* Z" l* q9 z* }Chairperson: Richard A. Young, PhD2 S1 b* g2 ?' E" h# {% Q' g
: Y: [2 L/ F! k0 H' {$ U6 }) b
Anna-Katerina Hadjantonakis, MD, Memorial Sloan-Kettering Cancer Center, USA 9 k1 V' M( ^" u0 V- t1 e
Ling-Ling Chen, PhD, Shanghai Institute for Biological Sciences, China
0 F2 ^" |8 [; S3 W4 e- C1 i# \+ f) ?% c& WMark Krasnow, MD, PhD, Stanford University School of Medicine, USA* u" n/ h9 h2 |' E
Ricardo A. Rossello, Howard Medical School
; p0 {, Y p- J' `1 X# }. H! rSheng Ding, Gladstone Institute, UCSF
' P' ?. k, o4 }0 Q4 H0 S3 a ~4 r1 l3 j$ L- q7 w
9.Friday, October 28 Closing Session: Cell Therapies! ?- C- p0 [5 i2 v* K
Chairperson and closing remarks: Ronald D. McKay, PhD
- u; i! T' v5 v: h) V: L# [: M% e+ U+ J/ z- z) M2 @
Lorenz Studer, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
- O( e! ` a. TKevin A. D'Amour, PhD, ViaCyte, Inc., USA: U0 N% K G; {% }' \7 F
Tariq Enver, The Weatherall Institute of Molecular Medicine, UK
2 z1 K( d: v s7 @4 h
% C y( z0 n; Z" b' S' AClosing Keynote: Gordon M. Keller, PhD, McEwen Center for Regenerative Medicine Ontario Cancer Institute, Canada8 d% B( r" o* w8 X
( K: [3 g* H8 ?4 T: G会场照片; ~4 C& D' h! d, @ |5 }/ C
5 o, w( a! T% |+ a3 G: c) Y/ [
: g0 W3 B- s2 I, H8 x- q
|
-
总评分: 威望 + 110
包包 + 220
查看全部评分
|
发表于 2011-10-31 20:02
发表于 2011-11-1 01:03
